Elekta : Invitation to the presentation of Elekta's fiscal year 2023/24
May 17, 2024 at 01:34 am EDT
Share
English
Swedish
Published: 2024-05-17 07:30:00 CEST
Elekta AB
Investor News
Invitation to the presentation of Elekta's fiscal year 2023/24
STOCKHOLM - Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2023/24 at 10:00 a.m. CET on June 5. The year-end report will be published at 7:30 a.m. CET on the same day.
The company's development will be presented by Elekta's President and CEO Gustaf Salford together with CFO Tobias Hägglöv. After the presentation, a Q&A session will follow.
The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta's website after the call.
For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 2906, e-mail: peter.nyquist@elekta.com
Time zone: CET (Central European Time)
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on "X", formerly known as Twitter.
Attachments:
Sweden Q4 2023 24 Invitation EN.pdf
This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page
Attachments
Original Link
Permalink
Disclaimer
Elekta AB published this content on
17 May 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
17 May 2024 05:33:01 UTC.
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).